Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?

OBJECTIVE: To compare discontinuation rates of first and second biologics in rheumatoid arthritis (RA) by tumour-necrosis factor inhibitor (TNFi) status and identify predictors and reasons for discontinuation. METHODS: From 1998 to 2011, self-reported medication use for RA was assessed every 6 month...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:RMD Open
Hlavní autoři: Ramiro, Sofia, Landewé, Robert, van der Heijde, Désirée, Harrison, David, Collier, David, Michaud, Kaleb
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2015
Témata:
Rheumatoid Arthritis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654098/
https://ncbi.nlm.nih.gov/pubmed/26629366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000155
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky